THE ULTIMATE GUIDE TO PHARMACEUTICAL INGREDIENTS

“The existing scenario has uncovered some structural weaknesses from the EU’s medicines supply chain and a significant dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides claimed. She recommended that supply chain challenges be resolved in an EU pharmaceutical approach envisioned being released by the end in the ye